Skip to content

Clinical trials

Phase 3 Osteoporosis, Postmenopausal trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis, Postmenopausal Phase: Phase 3 Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20044
20051
20062
20071
20081
20091
20111
20123
20132
20141
20182
20192
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
Amgen6
Radius Health, Inc.4
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Warner Chilcott2
Gedeon Richter Plc.1
Luye Pharma Group Ltd.1
Massachusetts General Hospital1
Sandoz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis, Postmenopausal30
Osteoporosis10
Bone Diseases, Metabolic8
Fractures, Bone4
Bone Diseases2
Musculoskeletal Diseases2
Back Pain1
Osteoporotic Fractures1
Spinal Fractures1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.